[What strategies are recommended for early stage disease? Other treatments]

Rev Neurol (Paris). 2000:156 Suppl 2 Pt 2:105-8.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use
  • Antioxidants
  • Antiparkinson Agents / therapeutic use*
  • Catechol O-Methyltransferase Inhibitors
  • Cholinergic Antagonists / therapeutic use
  • Clinical Trials as Topic
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Neuroprotective Agents / therapeutic use
  • Parkinson Disease / drug therapy*
  • Selegiline / therapeutic use

Substances

  • Antioxidants
  • Antiparkinson Agents
  • Catechol O-Methyltransferase Inhibitors
  • Cholinergic Antagonists
  • Enzyme Inhibitors
  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents
  • Selegiline
  • Amantadine